Sorafenib and CuB exert synergistic antitumor effects against hepatocellular carcinoma cells via inhibition of STAT3 phosphorylation.
Wang X, Li H, Li D, Bai Y, Zhang Y, Yan X, Li J, Zhao R, Liu J, Liu W, Shi M, Xu C, Yang T, Zhang T.
Wang X, et al. Among authors: li d, li j, li h.
FEBS Open Bio. 2021 Jan;11(1):133-145. doi: 10.1002/2211-5463.13035. Epub 2020 Nov 27.
FEBS Open Bio. 2021.
PMID: 33176070
Free PMC article.